Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Class of cardiac stem/progenitor cells</td><td align="center">Characterization</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Cardiac stem cells</td><td align="center">c-kit, Sca-1, Abcg-2, Flk-1, and WT1 </td></tr><tr><td align="left">Side population of cardiac stem cells</td><td align="center">Bcrp1</td></tr><tr><td align="left">Mesenchymal stem cells</td><td align="center">CD70<sup>+</sup>, CD90<sup>+</sup>,  CD105<sup>+</sup>, and CD34<sup>−</sup></td></tr><tr><td align="left">Cardiosphere-derived cells</td><td align="center">Cellular clusters from cardiac explants </td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Classes of cardiac stem/progenitor cells in the adult heart.

Stem Cells International

tab1

Table 1

Table 1: Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives 